Vigabatrin toxicity in children.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.Investigative ophthalmology & visual science · 2009
   Article
2. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.Documenta ophthalmologica. Advances in ophthalmology · 2008
   Article
3. OCT: New perspectives in neuro-ophthalmology.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
   Review

Corrections and comments

• Comment on
  Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.2004

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as